Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition

Minglu Zhou1, Chendong Liu1, Bo Li1

  • 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.

Nature Communications
|March 30, 2024
PubMed

Insights

Researchers developed nanothread "patches" to cluster cell surface receptors, enhancing therapeutic drug efficacy. This approach synchronizes mechano-transduction to disrupt signaling, showing promise in treating metastatic breast cancer.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Molecular Biology

Background:

  • Therapeutic antagonists often fail to effectively modulate downstream signaling pathways.
  • Receptor clustering is crucial for signal transduction but challenging to control therapeutically.

Purpose of the Study:

  • To develop a novel strategy for promoting receptor clustering using nanothreads.
  • To investigate the efficacy of this strategy in antagonizing chemokine receptors (CXCR4) in metastatic breast cancer.

Main Methods:

  • Designing two interactable nanothreads to create cell surface 'patches'.
  • Nanothread-1 links adjacent receptors and presents decoy receptors.
  • Nanothread-2 targets decoys, forming a supramolecular network to induce receptor clustering and mechano-transduction.

Main Results:

  • The nanothread strategy successfully clustered receptors, disrupting signal transmission.
  • Application in female mice with CXCR4-expressing metastatic breast cancer reduced tumor burden.
  • Observed benefits included interception of the metastatic cascade and reversal of immunosuppression.

Conclusions:

  • The nanothread-based approach provides a generalizable tool for spatial rearrangement of cell-surface receptors.
  • This strategy significantly improves therapeutic outcomes in preclinical models of metastatic breast cancer.
  • The technique enhances immunotherapy, such as photodynamic immunotherapy, for cancer treatment.